IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+14.97%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$493M
AUM Growth
+$493M
(+1.3%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
33.64%
Holding
86
New
21
Increased
22
Reduced
21
Closed
22
Top Buys
| 1 |
Baxter International
BAX
|
$16.2M |
| 2 |
Boston Scientific
BSX
|
$13.6M |
| 3 |
Biogen
BIIB
|
$13.4M |
| 4 |
Cardinal Health
CAH
|
$13.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
$9.56M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$15.5M |
| 2 |
AstraZeneca
AZN
|
$15.5M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.2M |
| 4 |
Elevance Health
ELV
|
$12.6M |
| 5 |
DexCom
DXCM
|
$12.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Atara Biotherapeutics
ATRA
$88.7M
| – | – |
-208,738
| Closed | -$1.63M |
|
|
77
AstraZeneca
AZN
$255B
| – | – |
-234,830
| Closed | -$15.5M |
|
|
78
DexCom
DXCM
$30.9B
| – | – |
-166,991
| Closed | -$12.4M |
|
79
Icon
ICLR
$14B
| – | – |
-31,311
| Closed | -$6.79M |
|
80
Insmed
INSM
$30.3B
| – | – |
-104,369
| Closed | -$2.06M |
|
81
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-20,874
| Closed | -$3.26M |
|
82
Kiniksa Pharmaceuticals
KNSA
$2.63B
| – | – |
-234,830
| Closed | -$2.28M |
|
83
Lexicon Pharmaceuticals
LXRX
$392M
| – | – |
-300,000
| Closed | -$558K |
|
84
Moderna
MRNA
$9.36B
| – | – |
-40,000
| Closed | -$5.71M |
|
85
Revvity
RVTY
$9.68B
| – | – |
-67,840
| Closed | -$9.65M |
|
86
Teladoc Health
TDOC
$1.37B
| – | – |
-124,369
| Closed | -$4.13M |
|